Oncogene

Article	Citations
Retraction Note to: FOXC2 promotes colorectal cancer metastasis by directly targeting MET	166
Retraction Note: Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma	159
Retraction Note: The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer	128
Retraction Note: RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine	127
Retraction Note: Genetic alterations of the NRP/B gene are associated with human brain tumors	124
Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells	118
Alcohol-induced C/EBP β-driven VIRMA decreases oxidative stress and promotes pancreatic ductal adenocarcinoma growth and metastasis via the m6A/YTHDF2/SLC43A2 pathway	116
Correction: p73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis	105
Retraction Note: HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis	104
Retraction Note: Human papillomavirus type 77 E6 protein selectively inhibits p53-dependent transcription of proapoptotic genes following UV-B irradiation	96
Correction: BRD4-specific PROTAC inhibits basal-like breast cancer partially through downregulating KLF5 expression	94
Editorial Expression of Concern: Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma	94
SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells	92
METTL3-mediated N6-methyladenosine modification of STAT5A promotes gastric cancer progression by regulating KLF4	87
The Hippo-YAP signaling pathway drives CD24-mediated immune evasion in esophageal squamous cell carcinoma via macrophage phagocytosis	85
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer	79
Flotillin-1 palmitoylation is essential for its stability and subsequent tumor promoting capabilities	78
DHODH inhibition represents a therapeutic strategy and improves abiraterone treatment in castration-resistant prostate cancer	77
TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer	76
The nerve cells in gastrointestinal cancers: from molecular mechanisms to clinical intervention	73
KLF5 regulates actin remodeling to enhance the metastasis of nasopharyngeal carcinoma	72
miR-147b mediated suppression of DUSP8 promotes lung cancer progression	72
Targeting STING elicits GSDMD-dependent pyroptosis and boosts anti-tumor immunity in renal cell carcinoma	70
CRL2KLHDC3 and CRL1Fbxw7 cooperatively mediate c-Myc degradation	68
ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions	65

An integrated ceRNA network identifies miR-375 as an upregulated miRNA playing a tumor suppressive role in aggressive prostate cancer	65
A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance	64
COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk	64
Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis	63
Correction: Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL	62
Correction: Regulation of cancer stem cell activity by thyroid hormone receptor β	62
FAK-LINC01089 negative regulatory loop controls chemoresistance and progression of small cell lung cancer	62
A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling	60
Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related Schwannomatosis	60
Mapping the breast tumor microenvironment: proximity analysis reveals spatial relationships between macrophage subtypes and metastasis-initiating cancer cells	60
Single-cell profiling reveals altered immune landscape and impaired NK cell function in gastric cancer liver metastasis	59
Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1	59
tRF-33-P4R8YP9LON4VDP inhibits gastric cancer progression via modulating STAT3 signaling pathway in an AGO2-dependent manner	57
scRNA‐seq reveals the landscape of immune repertoire of PBMNCs in iMCD	56
Correction: Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers	56
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks	56
N6-methyladenosine modified TGFB2 triggers lipid metabolism reprogramming to confer pancreatic ductal adenocarcinoma gemcitabine resistance	56
Alternative splicing of ALDOA confers tamoxifen resistance in breast cancer	54
EZH2 PROTACs target EZH2- and FOXM1-associated oncogenic nodes, suppressing breast cancer cell growth	54
RHNO1: at the crossroads of DNA replication stress, DNA repair, and cancer	54
ALDH1A3 is the switch that determines the balance of ALDH+ and CD24−CD44+ cancer stem cells, EMT-MET, and glucose metabolism in breast cancer	53
Characterisation of APOBEC3B-Mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs	53
NSUN2 regulates Wnt signaling pathway depending on the m5C RNA modification to promote the progression of hepatocellular carcinoma	53
Autophagy regulates the cancer stem cell phenotype of head and neck squamous cell carcinoma through the noncanonical FOXO3/SOX2 axis	52
Thymidylate synthase O-GlcNAcylation: a molecular mechanism of 5-FU sensitization in colorectal cancer	52
The keratin 17/YAP/IL6 axis contributes to E-cadherin loss and aggressiveness of diffuse gastric cancer	52
m6A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation	52
Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies	51
Dependence of PAX3-FOXO1 chromatin occupancy on ETS1 at important disease-promoting genes exposes new targetable vulnerability in Fusion-Positive Rhabdomyosarcoma	50
Emergence of β1 integrin-deficient breast tumours from dormancy involves both inactivation of p53 and generation of a permissive tumour microenvironment	50
PTPRZ1 dephosphorylates and stabilizes RNF26 to reduce the efficacy of TKIs and PD-1 blockade in ccRCC	49
Breathing new insights into the role of mutant p53 in lung cancer	48
Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma	48
Viral and cellular oncogenes promote immune evasion	47
Hypoxia induced cellular and exosomal RPPH1 promotes breast cancer angiogenesis and metastasis through stabilizing the IGF2BP2/FGFR2 axis	47
Correction: Regucalcin promotes dormancy of prostate cancer	46
Overcoming acquired resistance to third-generation EGFR inhibitors by targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition, Bax activation, or both	46
Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling	46
Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor	46
MAZ promotes tumor proliferation and immune evasion in lung adenocarcinoma	46
HSP90 inhibitors induce GPNMB cell-surface expression by modulating lysosomal positioning and sensitize breast cancer cells to glembatumumab vedotin	44
Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer	43
The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner	43
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer	43
TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer	42
A micropeptide XBP1SBM encoded by lncRNA promotes angiogenesis and metastasis of TNBC via XBP1s pathway	42
De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer	42
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion	42
EMT-mediated regulation of CXCL1/5 for resistance to anti-EGFR therapy in colorectal cancer	42
SKAP2 suppresses inflammation-mediated tumorigenesis by regulating SHP-1 and SHP-2	42

p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain)	41
GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling	41
Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer	41
USP13 promotes development and metastasis of high-grade serous ovarian carcinoma in a novel mouse model	41
Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation	41
MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer	41
IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist	41
H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth	41
XAF1 destabilizes estrogen receptor α through the assembly of a BRCA1-mediated destruction complex and promotes estrogen-induced apoptosis	40
CRL2KLHDC3 mediates p14ARF N-terminal ubiquitylation degradation to promote non-small cell lung carcinoma progression	40
Identification of a novel Calpain-2-SRC feed-back loop as necessity for β-Catenin accumulation and signaling activation in hepatocellular carcinoma	40
Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets	40
Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer	40
IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression	40
Structure and function of MuvB complexes	39
TFAM downregulation promotes autophagy and ESCC survival through mtDNA stress-mediated STING pathway	39
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1	38
Identification of low-frequency variants of UGT1A3 associated with bladder cancer risk by next-generation sequencing	38
ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma	38
A comprehensive analysis of LMO2 pathogenic regulatory profile during T-lineage development and leukemic transformation	38
Synthetic lethal kinases in Ras/p53 mutant squamous cell carcinoma	38
MARK2 regulates chemotherapeutic responses through class IIa HDAC-YAP axis in pancreatic cancer	37
ZnT7 RNAi favors RafGOFscrib−/−-induced tumor growth and invasion in Drosophila through JNK signaling pathway	37
Transcription associated cyclin-dependent kinases as therapeutic targets for prostate cancer	37
The role of miR-200b/c in balancing EMT and proliferation revealed by an activity reporter	37
Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma	37
Discovery of a dual WDR5 and Ikaros PROTAC degrader as an anti-cancer therapeutic	37
In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun	36
Gamma-glutamyltransferase 7 suppresses gastric cancer by cooperating with RAB7 to induce mitophagy	36
SCD5-dependent inhibition of SPARC secretion hampers metastatic spreading and favors host immunity in a TNBC murine model	36
Downregulation of HINFP induces senescence-associated secretory phenotype to promote metastasis in a non-cell-autonomous manner in bladder cancer	36
EZH2 regulates a SETDB1/ΔNp63α axis via RUNX3 to drive a cancer stem cell phenotype in squamous cell carcinoma	35
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma	35
Transcriptional regulation by MYC: an emerging new model	35
Correction: The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress	35
Linear ubiquitination of PTEN impairs its function to promote prostate cancer progression	35
Identification of novel germline mutations in FUT7 and EXT1 linked with hereditary multiple exostoses	35
The age of adult pilocytic astrocytoma cells	35
Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer	35
Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells	34
CRISPR screens identify a novel combination treatment targeting BCL-XL and WNT signaling for KRAS/BRAF-mutated colorectal cancers	34
Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand	34
Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition	34
Tumor resistance to radiotherapy is triggered by an ATM/TAK1-dependent-increased expression of the cellular prion protein	34
Loss of DLX3 tumor suppressive function promotes progression of SCC through EGFR–ERBB2 pathway	34
CXCR4 and CXCR7 signaling promotes tumor progression and obesity-associated epithelial-mesenchymal transition in prostate cancer cells	34
Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma	33
The lncRNA THOR interacts with and stabilizes hnRNPD to promote cell proliferation and metastasis in breast cancer	33
Correction: LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation	33
CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma	33
Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation	33
The role of polyamines in gastric cancer	33
Correction: SOX18 promotes gastric cancer metastasis through transactivating MCAM and CCL7	33
MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner	33
Ferroptosis as a mechanism to mediate p53 function in tumor radiosensitivity	33
The extracellular-regulated protein kinase 5 (ERK5) enhances metastatic burden in triple-negative breast cancer through focal adhesion protein kinase (FAK)-mediated regulation of cell adhesion	33
Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer	33
YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML	32
WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7	32
αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression	32
NK and NKT cells have distinct properties and functions in cancer	32
A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis	32
Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma	32
A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis	32
Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation	31
The FLI portion of EWS/FLI contributes a transcriptional regulatory function that is distinct and separable from its DNA-binding function in Ewing sarcoma	31
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer	31
Long non-coding RNA TILR constitutively represses TP53 and apoptosis in lung cancer	31
Monitoring the 5′UTR landscape reveals isoform switches to drive translational efficiencies in cancer	31
MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells	31
ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface	31
The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers	31
Altered gut microbiome composition by appendectomy contributes to colorectal cancer	30
NF-κB-activated SPRY4-IT1 promotes cancer cell metastasis by downregulating TCEB1 mRNA via Staufen1-mediated mRNA decay	30
N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing	30
Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells	30
Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome	30
Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells	30
PCNA regulates primary metabolism by scaffolding metabolic enzymes	30
Whole-transcriptome and proteome analyses identify key differentially expressed mRNAs, miRNAs, lncRNAs and circRNAs associated with HCC	30

Combination of chemotherapy with BRAF inhibitors results in effective eradication of malignant melanoma by preventing ATM-dependent DNA repair	30
Spatiotemporal view of malignant histogenesis and macroevolution via formation of polyploid giant cancer cells	30
Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma	29
The hTERT-p50 homodimer inhibits PLEKHA7 expression to promote gastric cancer invasion and metastasis	29
Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer	29
Applicability of liquid biopsies to represent the mutational profile of tumor tissue from different cancer entities	29
DNAJA1 promotes cancer metastasis through interaction with mutant p53	29
LIMK2 promotes melanoma tumor growth and metastasis through G3BP1-ESM1 pathway-mediated apoptosis inhibition	29
Sirt1 deficiency upregulates glutathione metabolism to prevent hepatocellular carcinoma initiation in mice	29
EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy	29
LncRNA XIST regulates breast cancer stem cells by activating proinflammatory IL-6/STAT3 signaling	29
TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer	29
KRAS phosphorylation regulates cell polarization and tumorigenic properties in colorectal cancer	28
Dual network analysis of transcriptome data for discovery of new therapeutic targets in non-small cell lung cancer	28
SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma	28
AMPK-deficiency forces metformin-challenged cancer cells to switch from carbohydrate metabolism to ketogenesis to support energy metabolism	28
New perspectives for targeting therapy in ALK-positive human cancers	28
Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming	28
Fermitin family member 2 promotes melanoma progression by enhancing the binding of p-α-Pix to Rac1 to activate the MAPK pathway	28
PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα	28
RAF1 contributes to cell proliferation and STAT3 activation in colorectal cancer independently of microsatellite and KRAS status	28
EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes	28
Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis	28
Glucose-mediated N-glycosylation of RPTPα affects its subcellular localization and Src activation	28
TMIGD1: Emerging functions of a tumor supressor and adhesion receptor	28
ITLN1 inhibits tumor neovascularization and myeloid derived suppressor cells accumulation in colorectal carcinoma	28
Glioma immunotherapy enhancement and CD8-specific sialic acid cleavage by isocitrate dehydrogenase (IDH)-1	28
NUDT22 promotes cancer growth through pyrimidine salvage	28
Deciphering glioma epitranscriptome: focus on RNA modifications	27
RNA binding protein RBMS3 is a common EMT effector that modulates triple-negative breast cancer progression via stabilizing PRRX1 mRNA	27
A novel amplification gene PCI domain containing 2 (PCID2) promotes colorectal cancer through directly degrading a tumor suppressor promyelocytic leukemia (PML)	27
PGC-1α promotes colorectal carcinoma metastasis through regulating ABCA1 transcription	27
Notch signaling regulates a metabolic switch through inhibiting PGC-1α and mitochondrial biogenesis in dedifferentiated liposarcoma	27
MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs	27
SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis	27
IER2-induced senescence drives melanoma invasion through osteopontin	27
RING-finger protein 6 promotes colorectal tumorigenesis by transcriptionally activating SF3B2	27
Pathologists’ first opinions on barriers and facilitators of computational pathology adoption in oncological pathology: an international study	27
YAP governs cellular adaptation to perturbation of glutamine metabolism by regulating ATF4-mediated stress response	26
Retraction Note: YAP1-induced MALAT1 promotes epithelial–mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer	26
miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche	26
FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations	26
MAD2 activates IGF1R/PI3K/AKT pathway and promotes cholangiocarcinoma progression by interfering USP44/LIMA1 complex	26
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium	26
Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway	26
ZNF545 loss promotes ribosome biogenesis and protein translation to initiate colorectal tumorigenesis in mice	26
C/ebpα represses the oncogenic Runx3–Myc axis in p53-deficient osteosarcoma development	26
Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity	26
Nup54-induced CARM1 nuclear importation promotes gastric cancer cell proliferation and tumorigenesis through transcriptional activation and methylation of Notch2	26
Commonalities and differences in the mutational signature and somatic driver mutation landscape across solid and hollow viscus organs	26
CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer	26
Activation of invasion by oncogenic reprogramming of cholesterol metabolism via increased NPC1 expression and macropinocytosis	26
Liprins in oncogenic signaling and cancer cell adhesion	26
Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells	26
The role of R-spondin proteins in cancer biology	26
TRAIP suppresses bladder cancer progression by catalyzing K48-linked polyubiquitination of MYC	25
VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner	25
FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation	25
PRAME induces genomic instability in uveal melanoma	25
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing E2F1 via USP11	25
Alleviating hypoxia to improve cancer immunotherapy	25
TKT-PARP1 axis induces radioresistance by promoting DNA double-strand break repair in hepatocellular carcinoma	25
MYC directly transactivates CR2/CD21, the receptor of the Epstein–Barr virus, enhancing the viral infection of Burkitt lymphoma cells	25
Clonal populations of a human TNBC model display significant functional heterogeneity and divergent growth dynamics in distinct contexts	25
GREB1 isoform 4 is specifically transcribed by MITF and required for melanoma proliferation	25
Glucocorticoid treatment influences prostate cancer cell growth and the tumor microenvironment via altered glucocorticoid receptor signaling in prostate fibroblasts	25
USP11 potentiates HGF/AKT signaling and drives metastasis in hepatocellular carcinoma	25
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma	25
Circular RNA EIF3I promotes papillary thyroid cancer progression by interacting with AUF1 to increase Cyclin D1 production	25
The cytotoxicity of γδT cells in non-small cell lung cancer mediated via coordination of the BCL-2 and AKT pathways	25
The urothelial gene regulatory network: understanding biology to improve bladder cancer management	25
NRF2 has a splicing regulatory function involving the survival of motor neuron (SMN) in non-small cell lung cancer	25
Blocking LBH expression causes replication stress and sensitizes triple-negative breast cancer cells to ATR inhibitor treatment	24
IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma	24
NFκB activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment	24
Correction to: Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential	24
Correction: LncFZD6 initiates Wnt/β-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation	24
Correction to: p14ARF inhibits the growth of lung adenocarcinoma cells harbouring an EGFR L858R mutation by activating a STAT3-dependent pro-apoptotic signalling pathway	24
Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL	24
Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program	24
Overcoming resistance to programmed cell death protein 1 (PD-1) blockade with allogeneic invariant natural killer T-cells (iNKT)	24
Regulation of Src tumor activity by its N-terminal intrinsically disordered region	24
Correction: Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer	24
Correction to: NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699	24
Correction: Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells	24
MZF1 mediates oncogene-induced senescence by promoting the transcription of p16INK4A	24
SIK2 maintains breast cancer stemness by phosphorylating LRP6 and activating Wnt/β-catenin signaling	24
BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer	24
Safety and efficacy of prophylactic and therapeutic vaccine based on live-attenuated Listeria monocytogenes in hepatobiliary cancers	24
Correction: Nuclear translocation of IGF-1R via p150Glued and an importin-β/RanBP2-dependent pathway in cancer cells	24
Correction: CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases	24
Correction: CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2	24
Regulation of cancer stem cell activity by thyroid hormone receptor β	24
PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression	24
A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling	23